{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:24:26Z","timestamp":1790310266213,"version":"4.1.0"},"reference-count":58,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Background: Despite the enormous efforts made towards combating tuberculosis (TB), the disease remains a major global threat. Hence, new drugs with novel mechanisms against TB are urgently needed. Fatty acid degradation protein D32 (FadD32) has been identified as a promising drug target against TB, the protein is required for the biosynthesis of mycolic acids, hence, essential for the growth and multiplication of the mycobacterium. However, the FadD32 mechanism upon the binding of FDA-approved drugs is not well established. Herein, we applied virtual screening (VS), molecular docking, and molecular dynamic (MD) simulation to identify potential FDA-approved drugs against FadD32. Methodology\/Results: VS technique was found promising to identify four FDA-approved drugs (accolate, sorafenib, mefloquine, and loperamide) with higher molecular docking scores, ranging from \u22128.0 to \u221210.0 kcal\/mol. Post-MD analysis showed that the accolate hit displayed the highest total binding energy of \u221245.13 kcal\/mol. Results also showed that the accolate hit formed more interactions with FadD32 active site residues and all active site residues displayed an increase in total binding contribution. RMSD, RMSF, Rg, and DCCM analysis further supported that the presence of accolate exhibited more structural stability, lower bimolecular flexibility, and more compactness into the FadD32 protein. Conclusions: Our study revealed accolate as the best potential drug against FadD32, hence a prospective anti-TB drug in TB therapy. In addition, we believe that the approach presented in the current study will serve as a cornerstone to identifying new potential inhibitors against a wide range of biological targets.<\/jats:p>","DOI":"10.3390\/molecules27030668","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T22:51:06Z","timestamp":1642719066000},"page":"668","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs"],"prefix":"10.3390","volume":"27","author":[{"given":"Nolwazi Thobeka Portia","family":"Ngidi","sequence":"first","affiliation":[{"name":"School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kgothatso Eugene","family":"Machaba","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-115X","authenticated-orcid":false,"given":"Ndumiso Nhlakanipho","family":"Mhlongo","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020). Global Tuberculosis Report, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1183\/13993003.00577-2015","article-title":"Benefit of treatment of latent tuberculosis infection in individual patients","volume":"46","author":"Dobler","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"a017863","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874467211666181025141114","article-title":"Kinase targets for mycolic acid biosynthesis in Mycobacterium tuberculosis","volume":"12","author":"Alsayed","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/acs.jmedchem.7b01319","article-title":"Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis","volume":"61","author":"Zhang","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2018.09.037","article-title":"Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors","volume":"28","author":"Fang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1042\/BCJ20200194","article-title":"The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host\u2019s immune system","volume":"447","author":"Batt","year":"2020","journal-title":"Biochem. J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kleandrova, V.V., Scotti, M.T., and Speck-Planche, A. (2021). Computational drug repurposing for antituberculosis therapy: Discovery of multi-strain inhibitors. Antibiotics, 10.","DOI":"10.3390\/antibiotics10081005"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2013.11.011","article-title":"Mycolic acids: Structures, biosynthesis, and beyond","volume":"21","author":"Marrakchi","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15493","DOI":"10.1038\/srep15493","article-title":"Crystal structure of FadD32, an enzyme essential for mycolic acid biosynthesis in mycobacteria","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/acsinfecdis.6b00082","article-title":"Structure of the Essential Mtb FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis","volume":"2","author":"Kuhn","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rudrapal, M., Khairnar, S.J., and Jadhav, A.G. (2020). Drug Repurposing (DR): An Emerging Approach in Drug Discovery. Drug Repurposing-Hypothesis Mol. Asp. Ther. Appl.","DOI":"10.5772\/intechopen.93193"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41598-020-80722-2","article-title":"Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay","volume":"11","author":"Diallo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijid.2014.12.031","article-title":"Repurposing-a ray of hope in tackling extensively drug resistance in tuberculosis","volume":"32","author":"Maitra","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"112175","DOI":"10.1016\/j.ejmech.2020.112175","article-title":"Repurposed drug candidates for antituberculosis therapy","volume":"192","author":"An","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sotgiu, G., D\u2019Ambrosio, L., Centis, R., Tiberi, S., Esposito, S., Dore, S., Spanevello, A., and Battista Migliori, G. (2016). Carbapenems to treat multidrug and extensively drug-resistant tuberculosis: A systematic review. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030373"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1021\/acs.jcim.0c01009","article-title":"New trends in virtual screening","volume":"60","author":"Walters","year":"2020","journal-title":"J. Chem. Inf. Modeling"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/s41598-020-60221-0","article-title":"Virtual screening as a tool to discover new \u03b2-haematin inhibitors with activity against malaria parasites","volume":"10","author":"Combrinck","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gimeno, A., Ojeda-Montes, M.J., Tom\u00e1s-Hern\u00e1ndez, S., Cereto-Massagu\u00e9, A., Beltr\u00e1n-Deb\u00f3n, R., Mulero, M., Pujadas, G., and Garcia-Vallve, S. (2019). The light and dark sides of virtual screening: What is there to know?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061375"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fchem.2020.00343","article-title":"Structure-Based Virtual Screening: From Classical to Artificial Intelligence","volume":"8","author":"Maia","year":"2020","journal-title":"Front. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08927028808080941","article-title":"A leap-frog algorithm for stochastic dynamics","volume":"1","author":"Berendsen","year":"1988","journal-title":"Mol. Simul."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.sbi.2019.12.016","article-title":"Machine learning approaches for analyzing and enhancing molecular dynamics simulations","volume":"61","author":"Wang","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0006-3495(03)74462-2","article-title":"Protocol for MM\/PBSA molecular dynamics simulations of proteins","volume":"85","author":"Fogolari","year":"2003","journal-title":"Biophys. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e04944","DOI":"10.1016\/j.heliyon.2020.e04944","article-title":"Application of per-residue energy decomposition to identify the set of amino acids critical for in silico prediction of COX-2 inhibitory activity","volume":"6","author":"Chaudhary","year":"2020","journal-title":"Heliyon"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2174\/1381612819666131118203641","article-title":"New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics","volume":"20","author":"North","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1021\/ci0504925","article-title":"Root mean square deviation probability analysis of molecular dynamics trajectories on DNA","volume":"46","author":"Dixit","year":"2006","journal-title":"J. Chem. Inf. Modeling"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.102179699","article-title":"Evaluating conformational free energies: The colony energy and its application to the problem of loop prediction","volume":"99","author":"Xiang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sneha, P., and Priya Doss, C.G. (2016). Molecular Dynamics: New Frontier in Personalized Medicine. Advances in Protein Chemistry and Structural Biology, Elsevier Inc.. [1st ed.].","DOI":"10.1016\/bs.apcsb.2015.09.004"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1080\/07391102.2019.1677501","article-title":"Exploring the impact of H5N1 neuraminidase (H274Y) mutation on Peramivir: A bio-computational study from a molecular perspective","volume":"38","author":"Buthelezi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_30","first-page":"1","article-title":"Correlated Motions and Dynamics in Different Domains of EGFR with L858R and T790M Mutations","volume":"5963","author":"Qureshi","year":"2020","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11224-019-01305-0","article-title":"Molecular alteration in drug susceptibility against subtype B and C-SA HIV-1 proteases: MD study","volume":"30","author":"Halder","year":"2019","journal-title":"Struct. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gupta, N., Choudhary, S.K., Bhagat, N., Karthikeyan, M., and Chaturvedi, A. (2021). In silico prediction, molecular docking and dynamics studies of steroidal alkaloids of holarrhena pubescens wall. ex G. don to guanylyl cyclase C: Implications in designing of novel antidiarrheal therapeutic strategies. Molecules, 26.","DOI":"10.3390\/molecules26144147"},{"key":"ref_34","first-page":"65","article-title":"Leukotriene inhibitors in the treatment of allergy and asthma","volume":"75","author":"Scow","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/sti.2002.003491","article-title":"Zafirlukast for severe recurrent vulvovaginal candidiasis: An open label pilot study","volume":"80","author":"White","year":"2004","journal-title":"Sex. Transm. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1872-034X.2012.01113.x","article-title":"Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update","volume":"43","author":"Gauthier","year":"2013","journal-title":"Hepatol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcpt.12365","article-title":"The adverse effects of sorafenib in patients with advanced cancers","volume":"116","author":"Li","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/1475-2875-12-451","article-title":"Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique","volume":"12","author":"Gobbi","year":"2013","journal-title":"Malar. J."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lee, S.J., Ter Kuile, F.O., Price, R.N., Luxemburger, C., and Nosten, F. (2017). Adverse effects of Mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0168780"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpainsymman.2011.06.001","article-title":"Loperamide","volume":"42","author":"Regnard","year":"2011","journal-title":"J. Pain Symptom Manag."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/20009666.2020.1766839","article-title":"\u2018Loperamide overdose induces ventricular tachycardia with catastrophic outcomes\u2019","volume":"10","author":"Ali","year":"2020","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jiph.2020.06.023","article-title":"Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis","volume":"13","author":"Sundarsingh","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1074\/jbc.M115.712612","article-title":"Insight into structure-function relationships and inhibition of the fatty Acyl-AMP ligase (FadD32) orthologs from mycobacteria","volume":"291","author":"Guillet","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41429-020-0320-7","article-title":"Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis","volume":"73","author":"Lelovic","year":"2020","journal-title":"J. Antibiot."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15\u2014Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Modeling"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/nar\/gku377","article-title":"Enhancing UCSF Chimera through web services","volume":"42","author":"Huang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.12691\/wjce-5-4-4","article-title":"Avogadro Program for Chemistry Education: To What Extent can Molecular Visualization and Three-dimensional Simulations Enhance Meaningful Chemistry Learning?","volume":"5","author":"Rayan","year":"2017","journal-title":"World J. Chem. Educ."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jcc.21600","article-title":"Software News and Updates Gabedit\u2014A Graphical User Interface for Computational Chemistry Softwares","volume":"32","author":"Allouche","year":"2012","journal-title":"J. Comput. Chem."},{"key":"ref_49","unstructured":"Case, D.A., Babin, V., Berryman, J.T., Betz, R.M., Cai, Q., Cerutti, D.S., Cheatham, T.E., Darden, T.A., Duke, R.E., and Gohlke, H. (2014). AMBER 14, University of California."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"56531","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"124109","DOI":"10.1063\/1.5043614","article-title":"Effects of thermostatting in molecular dynamics on anharmonic properties of crystals: Application to fcc Al at high pressure and temperature","volume":"149","author":"Moustafa","year":"2018","journal-title":"J. Chem. Phys."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Singh, N., and Li, W. (2020). Absolute binding free energy calculations for highly flexible protein MDM2 and its inhibitors. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134765"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kasahara, K., Fukuda, I., and Nakamura, H. (2014). A novel approach of dynamic cross correlation analysis on molecular dynamics simulations and its application to Ets1 dimer-DNA complex. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112419"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13321-018-0259-x","article-title":"Key features and updates for origin 2018","volume":"10","author":"Moberly","year":"2018","journal-title":"J. Cheminformatics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12013-016-0764-3","article-title":"Sliding Clamp of DNA Polymerase III as a Drug Target for TB Therapy: Comprehensive Conformational and Binding Analysis from Molecular Dynamic Simulations","volume":"74","author":"Machaba","year":"2016","journal-title":"Cell Biochem. Biophys."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/3\/668\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:04:39Z","timestamp":1760133879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/3\/668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["molecules27030668"],"URL":"https:\/\/doi.org\/10.3390\/molecules27030668","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}